Ellevest, Inc. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2023$397
+4.2%
430.0%0.00%
Q4 2022$381
-61.9%
43
-35.8%
0.00%
Q3 2022$1,0000.0%67
-39.6%
0.00%
Q2 2022$1,000
-75.0%
111
-78.1%
0.00%
Q1 2022$4,000
+300.0%
506
+237.3%
0.00%
Q4 2021$1,000
-66.7%
150
-7.4%
0.00%
Q3 2021$3,000
+200.0%
162
+113.2%
0.00%
Q2 2021$1,0000.0%76
+123.5%
0.00%
Q1 2021$1,000340.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2021
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders